BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//6.0.1.1//EN
BEGIN:VEVENT
UID:58c651cb-db6e-41c4-afba-0b1d956503c7
DTSTART:20260504T080000Z
DTEND:20260505T170000Z
DTSTAMP:20260314T190046Z
SUMMARY:2nd Tumour Models Summit Malmo
DESCRIPTION:Selecting and Optimising Predictive and Cost-Effective Models to Enhance Target Selection\, Facilitate Biomarker Discovery and Achieve Clinical Translatability\n2026 is set to reshape the future of preclinical oncology.\n\nAs we close out 2025 with the UK accelerating its roadmap to phase out animal testing and SillaJen securing a landmark FDA approval using only organoid efficacy data\, the momentum has never been stronger. With immunomodulating therapies surging and preclinical development costs continuing to climb\, the pressure is on for biopharma to cut attrition and de-risk every preclinical decision.\n\nThe message is clear: investing in more trustworthy\, physiologically relevant\, and cost-effective models is now mission-critical for successfully advancing assets worldwide.\n\nJoin your peers at the Tumour Models Summit Malmo as the industry's leading minds unite to navigate this paradigm shift and define the future of preclinical oncology.
LOCATION:Clarion Hotel Malmo Live\, 2 Dag Hammarskjolds torg\, Malmo\, Skane lan\, 211 18\, Sweden
URL:https://eventstopten.com/events/2nd-tumour-models-summit-malmo/
END:VEVENT
END:VCALENDAR